Your sourcing partner for pharmaceutical solutions

› Specialized product portfolio
› Technical support
› Regulatory support

Our Portfolio

APIs

Excipients

Process Aids & Equipment

Excipients for topical and oral applications like skin protectants, carriers, rheological modifiers, sweeteners, humectants, fillers, binders and disintegrants.

Our Portfolio

Our Support

Our Services

Support

› Specialised product portfolio

› Technical consultation

› Formulation development

Relations

› Long-term partnerships
› Global sourcing network
› Transparency

Quality

› Regulatory support

› GDP certification

› Compendial and

GMP compliant materials

Learn More

Our Portfolio

Our Support

Our Services

Support

› Specialised product portfolio

› Technical consultation

› Formulation development

Learn more

Quality

› Regulatory support

› GDP certification

› Compendial and
GMP compliant materials

› Long-term partnerships
› Global sourcing network
›  Transparency

Relations

Our Support

From idea to solution

Project assessment

Material selection

Formulation development

Raw material qualification

Supply for production

Interested? Get in touch

Our Services

Support

› Specialised
 product portfolio
› Technical
 consultation
› Formulation
 development

Quality

› Regulatory support
› GDP certification
› Compendial and GMP compliant

materials

Relations

› Long-term
 partnerships
› Global sourcing
 network
› Transparency

Learn more

www.biesterfeld.com

healthcare@biesterfeld.com

Follow us

First class suppliers

Technical product support

Portfolio

Formulation

Development

Go to article: Home | Waive goodbye to vaccine patentsGo to article: In this issueGo to article: ContentsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: DatwylerGo to article: Datwyler Company InsightGo to article: LabcorpGo to article: Biesterfeld Go to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Dr. Paul LohmannGo to article: ButterworthGo to article: SkyepharmaGo to article: BaxterGo to article: CommentGo to article: Speeding up patient access to innovative drugsGo to article: The competitive landscape of neoantigen-targeting therapeutics in oncologyGo to article: Bacterial “cell factories”: an eco-friendly approach to chemical productionGo to article: MDR set to transform how MedTech firms approach content managementGo to article: PerkinElmerGo to article: NiproGo to article: NiproGo to article: In DepthGo to article: Should UK children be vaccinated against chickenpox?Go to article: Fighting India’s ‘black fungus’ epidemicGo to article: What could a vaccine patent waiver mean for pharma manufacturing? Go to article: Algae proteins: a vision of the futureGo to article: A brief history of ALS awareness and its sparse treatments Go to article: Ferring draws closer to a microbiome breakthroughGo to article: The Solubility companyGo to article: Myonex Go to article: Owen MumfordGo to article: In DataGo to article: Data: pharma subsidiaries Go to article: Deals analysisGo to article: The pharma industry key listGo to article: Global markets and indicesGo to article:  Macro-economic indicatorsGo to article: Macro-economic indicators (page 2)Go to article: EventsGo to article: Next issue